The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment

le Pennock, Gregory K., Chow, Laura Q.M.
Foilsithe in Oncologist (2015)

Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma

le Chamberlain, Marc C., Baik, Christina S., Gadi, Vijayakrishna K., Bhatia, Shailender, Chow, Laura Q.M.
Foilsithe in Neuro Oncol (2017)

Unmet needs and opportunities for improving care for patients with advanced lung cancer on targeted therapies: a qualitative study

le Al Achkar, Morhaf, Marchand, Lucille, Thompson, Matthew, Chow, Laura Q M, Revere, Debra, Baldwin, Laura-Mae
Foilsithe in BMJ Open (2020)

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in pat...

le Chow, Laura Q. M., Eckhardt, S. Gail, O’Bryant, Cindy L., Schultz, Mary Kay, Morrow, Mark, Grolnic, Stacy, Basche, Michele, Gore, Lia
Foilsithe 2007

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

le Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M., Forde, Patrick M.
Foilsithe in Clin Cancer Res (2017)

Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors

le Chow, Laura Q. M., Smith, David C., Tan, Antoinette R., Denlinger, Crystal S., Wang, Ding, Shepard, Dale R., Chaudhary, Archana, Lin, Yong, Gao, Ling
Foilsithe in Cancer Chemother Pharmacol (2016)

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities

le Baik, Christina S., Rubin, Eric H., Forde, Patrick M., Mehnert, Janice M., Collyar, Deborah, Butler, Marcus O., Dixon, Erica L., Chow, Laura Q.M.
Foilsithe in Clin Cancer Res (2017)

Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer

le Hellmann, Matthew D., Gettinger, Scott, Chow, Laura Q. M., Gordon, Michael, Awad, Mark M., Cha, Edward, Gong, Xiaohua, Zhou, Gongfu, Walker, Chris, Leopold, Lance, Heist, Rebecca S.
Foilsithe in Int J Cancer (2020)

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

le Nanda, Rita, Chow, Laura Q.M., Dees, E. Claire, Berger, Raanan, Gupta, Shilpa, Geva, Ravit, Pusztai, Lajos, Pathiraja, Kumudu, Aktan, Gursel, Cheng, Jonathan D., Karantza, Vassiliki, Buisseret, Laurence
Foilsithe in J Clin Oncol (2016)

Adjuvant Radiotherapy for Stages II and III Resected Thymoma: a Single Institution Experience

le Yan, Jinchun, Liu, Qin, Moseley, Jessica N., Baik, Christina S., Chow, Laura Q. M., Goulart, Bernardo H. M., Zlotnick, David, Papanicolau-Sengos, Antoni, Gallaher, Ian, Knopp, Joy M., Zeng, Jing, Patel, Shilpen
Foilsithe in Am J Clin Oncol (2016)

A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma

le Méndez, Eduardo, Rodriguez, Cristina P., Kao, Michael C., Raju, Sharat, Diab, Ahmed, Harbison, R. Alex, Konnick, Eric Q., Mugundu, Ganesh M., Santana-Davila, Rafael, Martins, Renato, Futran, Neal D., Chow, Laura Q.M.
Foilsithe in Clin Cancer Res (2018)

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies

le Chow, Laura Q. M., Gustafson, Daniel L., O’Bryant, Cindy L., Gore, Lia, Basche, Michele, Holden, Scott N., Morrow, Mark C., Grolnic, Stacy, Creese, Brian R., Roberts, Kaye L., Davis, Kat, Addison, Russell, Eckhardt, S. Gail
Foilsithe 2008

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients with Non-Small-Cell Lung Cancer

le Spigel, David R., Chaft, Jamie E., Gettinger, Scott, Chao, Bo H., Dirix, Luc, Schmid, Peter, Chow, Laura Q. M., Hicks, Rodney J., Leon, Larry, Fredrickson, Jill, Kowanetz, Marcin, Sandler, Alan, Funke, Roel, Rizvi, Naiyer A.
Foilsithe in J Thorac Oncol (2018)

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

le Creelan, Benjamin C., Yeh, Tammie C., Kim, Sang-We, Nogami, Naoyuki, Kim, Dong-Wan, Chow, Laura Q. M., Kanda, Shintaro, Taylor, Rosemary, Tang, Weifeng, Tang, Mei, Angell, Helen K., Roudier, Martine P., Marotti, Marcelo, Gibbons, Don L.
Foilsithe in Br J Cancer (2020)

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G(1) Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor...

le Spratlin, Jennifer L., Cohen, Roger B., Eadens, Matthew, Gore, Lia, Camidge, D. Ross, Diab, Sami, Leong, Stephen, O'Bryant, Cindy, Chow, Laura Q.M., Serkova, Natalie J., Meropol, Neal J., Lewis, Nancy L., Chiorean, E. Gabriela, Fox, Floyd, Youssoufian, Hagop, Rowinsky, Eric K., Eckhardt, S. Gail
Foilsithe 2010

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

le Mehra, Ranee, Seiwert, Tanguy Y., Gupta, Shilpa, Weiss, Jared, Gluck, Iris, Eder, Joseph P., Burtness, Barbara, Tahara, Makoto, Keam, Bhumsuk, Kang, Hyunseok, Muro, Kei, Geva, Ravit, Chung, Hyun Cheol, Lin, Chia-Chi, Aurora-Garg, Deepti, Ray, Archana, Pathiraja, Kumudu, Cheng, Jonathan, Chow, Laura Q. M., Haddad, Robert
Foilsithe in Br J Cancer (2018)

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non—Small-Cell Lung Cancer and Activating Epidermal Growth Factor...

le Leighl, Natasha B., Rizvi, Naiyer A., de Lima, Lopes Gilberto, Arpornwirat, Wichit, Rudin, Charles M., Chiappori, Alberto A., Ahn, Myung-Ju, Chow, Laura Q.M., Bazhenova, Lyudmila, Dechaphunkul, Arunee, Sunpaweravong, Patrapim, Eaton, Keith, Chen, Jihong, Medley, Sonja, Poondru, Srinivasu, Singh, Margaret, Steinberg, Joyce, Juergens, Rosalyn A., Gadgeel, Shirish M.
Foilsithe in Clin Lung Cancer (2016)

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

le Antonia, Scott J, Borghaei, Hossein, Ramalingam, Suresh S, Horn, Leora, De Castro Carpeño, Javier, Pluzanski, Adam, Burgio, Marco A, Garassino, Marina, Chow, Laura Q M, Gettinger, Scott, Crinò, Lucio, Planchard, David, Butts, Charles, Drilon, Alexander, Wojcik-Tomaszewska, Joanna, Otterson, Gregory A, Agrawal, Shruti, Li, Ang, Penrod, John R, Brahmer, Julie
Foilsithe in Lancet Oncol (2019)

Intracranial and whole-body response of ceritinib in ALK inhibitor-naïve and previously ALK inhibitor-treated patients with ALK-rearranged non-small-cell lung cancer (NSCLC): updat...

le Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S W, Felip, Enriqueta, Chow, Laura Q M, Camidge, D Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Jürgen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Sutradhar, Santosh, Li, Siyu, Szczudlo, Tomasz, Yovine, Alejandro, Shaw, Alice T
Foilsithe in Lancet Oncol (2016)

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

le Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
Foilsithe 2014